Biotech

All Articles

Daiichi pays Merck $170M to form lung cancer cells T-cell engager treaty

.Merck &amp Co. has actually quickly recovered several of the costs of its Javelin Therapeutics buyo...

BioMarin standstills preclinical genetics therapy for heart condition

.After BioMarin conducted a spring season tidy of its pipeline in April, the provider has chosen tha...

Eisai plants molecular glue SEED with $1.5 B biobucks deal

.Major Pharmas continue to be caught to the concept of molecular glue degraders. The latest firm to ...

Life scientific research credit report firm unveils with $600M

.A brand-new global life science credit score agency, termed Symbiotic Funds, has increased greater ...

BMS trenches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing another big bet from the Caforio age, ending an offer for Agenus' TIG...

Nuvation stops BET prevention after thinking about period 1 information

.After having a look at phase 1 data, Nuvation Bio has decided to halt service its one-time top BD2-...

' Professional instinct' led FDA consultants to support Zevra's rare health condition med

.Zevra Rehabs' unusual disease medication seems to become on the pathway to approval this autumn aft...

Pfizer takes $230M attacked after axing failed DMD genetics therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics treatment failing has gone a $230 milli...

AC Immune observes 'landmark' prospective in Alzheimer's medicine information

.After more than 20 years of service neurodegenerative illness, Swiss biotech AC Immune system cases...

GSK drops ph. 2 HPV injection over lack of best-in-class prospective

.GSK has actually scrapped a period 2 individual papillomavirus (HPV) injection from its own pipelin...